Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate

Jaime Pablo Kelly Rigollet, Joan Anton Ondategui, Angels Pasto, Laura Lop, Institut Catal&agrave; de la Salut, Centre de Atenci&oacute; Prim&agrave;ria MANSO, Eixample esquerra, Barcelona, Spain, The results of this were first presented in the World Glaucoma Congress, Boston...

Full description

Bibliographic Details
Main Authors:	Jaime Pablo Kelly Rigollet, Joan Anton Ondategui, Angels Pasto, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-02-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/randomized-trial-comparing-three-fixed-combinations-of-prostaglandinsp-a6281

Similar Items

Misidentification of prostamides as prostaglandins
by: Michelle Glass, et al.
Published: (2005-07-01)

Comparison of the effects of antiglaucomatous fixed combinations and patients compliance: Dorzolamide-timolol maleate and latanoprost-timolol maleate
by: Kubilay Çetinkaya, et al.
Published: (2012-03-01)

Safety and Efficacy of Adding Fixed-Combination Brinzolamide/Timolol Maleate to Prostaglandin Therapy for Treatment of Ocular Hypertension or Glaucoma
by: Anton Hommer, et al.
Published: (2015-01-01)

Ocular surface evaluation in patients treated with a fixed combination of prostaglandin analogues with 0.5% timolol maleate topical monotherapy: a randomized clinical trial
by: Heloisa Helena Russ, et al.

Avaliação econômica das associações fixas de prostaglandina/prostamida e timolol no tratamento do glaucoma e da hipertensão ocular Economic evaluation of Prostaglandin/Prostamide and timolol fixed combinations in the treatment of glaucoma and ocular hypertension
by: Ricardo Augusto Paletta Guedes, et al.
Published: (2010-08-01)

The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
by: Radcliffe NM
Published: (2014-12-01)

Transdermal iontophoretic delivery of timolol maleate
by: Mayur Patni, et al.
Published: (2012-12-01)

Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension
by: Frenkel Ronald EP, et al.
Published: (2007-09-01)

Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue
by: Nakano T, et al.
Published: (2016-12-01)

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy
by: Norbert Pfeiffer, et al.
Published: (2010-05-01)

Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate
by: Muge Gulen, et al.
Published: (2014-08-01)

Optimization of Thermoreversible In Situ Nasal Gel of Timolol Maleate
by: Swati Jagdale, et al.
Published: (2016-01-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy
by: Ai-Wei Liu, et al.
Published: (2016-05-01)

Studies on the effect of timolol maleate on human corneal endothelial cells
by: Ting-Jun Fan, et al.
Published: (2013-06-01)

Topical timolol maleate: An effectual and safe recourse for infantile hemangiomas
by: Yasmeen Jabeen Bhat, et al.
Published: (2016-01-01)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
by: Kakoli Roy, et al.
Published: (2012-01-01)

Conjunctival changes induced by prostaglandin analogues and timolol maleate: a histomorphometric study Alterações conjuntivais induzidas por análogos de prostaglandinas e maleato de timolol: estudo histomorfométrico
by: Heloisa Helena Abil Russ, et al.
Published: (2007-12-01)

Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study
by: Kumar Harsh, et al.
Published: (2002-01-01)

Daily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and Sweden
by: Anders Bergstr&ouml;m, et al.
Published: (2009-08-01)

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs
by: Inoue K, et al.
Published: (2012-02-01)

The Yijing Buyang Huanwu Decoction combined with timolol maleate in the treatment of POAG
by: Xiao-Rong Zhang, et al.
Published: (2021-02-01)

Oftalmik Timolol Maleat Kullanımına Bağlı Semptomatik Bradikardi ve Senkop
by: Müge GÜLEN, et al.
Published: (2014-07-01)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
by: Vinod Singh, et al.
Published: (2011-01-01)

Comment on "Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate"
by: Cynthia Arunachalam
Published: (2013-01-01)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015-04-01)

Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy
by: Kazuyoshi Kitamura, et al.
Published: (2018-01-01)

Design and evaluation of guargum - based timolol maleate ocular insert For the treatment of glaucoma
by: Sunil Thakral
Published: (2015-12-01)

Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
by: Mitsuhiro Isaka, et al.
Published: (2021-08-01)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010-11-01)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
by: Hai Wei Wu, et al.
Published: (2017-06-01)

Simultaneous spectrofluorometric analysis of tablets containing hydrochlorothiazide combined with timolol maleate or amiloride hydrochloride
by: Wedian Fadel, et al.
Published: (2020-09-01)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
by: Moisseiev E,&nbsp;Lazar M, et al.
Published: (2012-02-01)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
by: Kenji Inoue, et al.
Published: (2014-01-01)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
by: Mary S Galose, et al.
Published: (2016-01-01)

Enzymatic formation of prostamide F2α from anandamide involves a newly identified intermediate metabolite, prostamide H2
by: Wu Yang, et al.
Published: (2005-12-01)

Efficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.
by: Miao He, et al.
Published: (2013-01-01)

Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy
by: Hasebe Y, et al.
Published: (2018-08-01)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
by: Inoue K, et al.
Published: (2014-07-01)